Bank of Montreal’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,155
| Closed | -$422 | – | 4585 |
|
|
2022
Q3 | $422 | Sell |
8,155
-49
| -0.6% | -$2.02K | ﹤0.01% | 2688 |
|
|
2022
Q2 | $213 | Sell |
8,204
-574
| -7% | -$12.7K | ﹤0.01% | 3238 |
|
|
2022
Q1 | $219K | Buy |
8,778
+103
| +1% | +$2.9K | ﹤0.01% | 3407 |
|
|
2021
Q4 | $321K | Sell |
8,675
-87,475
| -91% | -$3.07M | ﹤0.01% | 2684 |
|
|
2021
Q3 | $1.88M | Buy |
96,150
+941
| +1% | +$14.7K | ﹤0.01% | 2111 |
|
|
2021
Q2 | $1.34M | Buy |
95,209
+5,655
| +6% | +$139K | ﹤0.01% | 2302 |
|
|
2021
Q1 | $4.4M | Sell |
89,554
-6,019
| -6% | -$362K | ﹤0.01% | 1416 |
|
|
2020
Q4 | $5.96M | Buy |
95,573
+93,101
| +3,766% | +$5.33M | ﹤0.01% | 1287 |
|
|
2020
Q3 | $146K | Sell |
2,472
-1,303
| -35% | -$70.2K | ﹤0.01% | 2891 |
|
|
2020
Q2 | $223K | Buy |
3,775
+3,646
| +2,826% | +$198K | ﹤0.01% | 2672 |
|
|
2020
Q1 | $5K | Sell |
129
-5,494
| -98% | -$233K | ﹤0.01% | 3699 |
|
|
2019
Q4 | $223K | Buy |
5,623
+2,055
| +58% | +$36.1K | ﹤0.01% | 3103 |
|
|
2019
Q3 | $24K | Sell |
3,568
-75,322
| -95% | -$565K | ﹤0.01% | 4007 |
|
|
2019
Q2 | $733K | Sell |
78,890
-44,753
| -36% | -$518K | ﹤0.01% | 2225 |
|
|
2019
Q1 | $1.72M | Sell |
123,643
-5,440
| -4% | -$62.2K | ﹤0.01% | 1763 |
|
|
2018
Q4 | $1.41M | Sell |
129,083
-1,599
| -1% | -$16.9K | ﹤0.01% | 1716 |
|
|
2018
Q3 | $1.65M | Buy |
130,682
+26,578
| +26% | +$320K | ﹤0.01% | 1775 |
|
|
2018
Q2 | $1.37M | Buy |
104,104
+93,276
| +861% | +$1.12M | ﹤0.01% | 1841 |
|
|
2018
Q1 | $148K | Sell |
10,828
-2,304
| -18% | -$23.8K | ﹤0.01% | 2784 |
|
|
2017
Q4 | $78K | Hold |
13,132
| – | – | ﹤0.01% | 3103 |
|
|
2017
Q3 | $98K | Buy |
13,132
+2,138
| +19% | +$17.8K | ﹤0.01% | 2988 |
|
|
2017
Q2 | $102K | Buy |
+10,994
| New | +$80.7K | ﹤0.01% | 2985 |
|
|
2016
Q3 | – | Sell |
-32,059
| Closed | -$144K | – | 4251 |
|
|
2016
Q2 | $144K | Buy |
32,059
+27,998
| +689% | +$105K | ﹤0.01% | 2637 |
|
|
2016
Q1 | $10K | Buy |
4,061
+2,604
| +179% | +$9.48K | ﹤0.01% | 3633 |
|
|
2015
Q4 | $12K | Buy |
+1,457
| New | +$10.3K | ﹤0.01% | 3578 |
|
|
2015
Q1 | – | Sell |
-10,000
| Closed | -$68K | – | 4256 |
|
|
2014
Q4 | $68K | Buy |
+10,000
| New | +$52.9K | ﹤0.01% | 2945 |
|
|
2014
Q3 | – | Sell |
-640
| Closed | -$4K | – | 4520 |
|
|
2014
Q2 | $4K | Buy |
+640
| New | +$3.59K | ﹤0.01% | 4303 |
|
Other funds holding CCXI
Bank of Montreal's CCXI Position: Q4 2022 in Review
Bank of Montreal sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 8,155 shares — an estimated $422 sold.
Bank of Montreal first reported a position in CCXI in Q2 2014 and held it in 27 quarters. The position peaked at $5.96M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Bank of Montreal reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Bank of Montreal sold 8,155 ChemoCentryx, Inc. shares in Q4 2022, an estimated $422.
- Bank of Montreal first reported a position in ChemoCentryx, Inc. in Q2 2014 and held it in 27 quarters.
- Bank of Montreal's ChemoCentryx, Inc. position peaked at $5.96M in Q4 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.